| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.006 |